- 4.8Impact Factor
- 9.2CiteScore
- 20 daysTime to First Decision
Special Issues
Cells publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Molecular Insights into Quantum Biology
Deadline: 31 December 2026
Cellular Regulation of Inflammatory Diseases
Deadline: 31 December 2026
Human ABC Transporters in Drug Disposition and Resistance: 50 Years of Progress and Future Perspectives
Deadline: 31 December 2026
Biomolecules in Mycobacterial Pathogenesis, Host–Pathogen Interactions, and Antimicrobial and Therapeutic Approaches
Deadline: 31 December 2026
Molecular, Cellular, and Blood Biomarkers in Diagnosis, Prognosis, Monitoring, and Treatment: 2nd Edition
Deadline: 31 December 2026
Recent Molecular Research on Protein Structure and Function
Deadline: 15 December 2026
Computational Pharmacology: Advances in Computational Modeling of Drug–Receptor Interactions and Pharmacokinetics
Deadline: 30 October 2026
Novel Molecular Targets for Beta Cell Regeneration and Diabetes Therapy
Deadline: 30 October 2026
The Function of Stromal Cells in Gastrointestinal (GI) Diseases
Deadline: 23 October 2026
Role of Lipids in Cellular Metabolism and Communication
Deadline: 30 September 2026
Advances in Targeted At-211 Alpha Therapy
Deadline: 30 September 2026
The Impact of Blood Pressure on Neurological Outcomes
Deadline: 30 September 2026
of 97

